This contract is for the contractor to provide support for essential core activities that are to be performed on a regular basis. This includes: 1) project management; 2) quality assurance/quality…
Ended Awarded Last action
- Contract number
- HHSN27200039
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,826,332
Award facts
- Contract value 100% obligated
- $1,826,332.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$41,608 | |
| Funding Only Action | -$23,411 | |
| Funding Only Action | $105,254 | |
| Exercise an Option | $394,216 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $385,578 | |
| Exercise an Option | $351,370 | |
| Original award | $654,933 |
About this award
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development programs. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and does not have a set-aside designation.
ABL is a leading contract research and manufacturing organization that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. Through this contract and other Indefinite Delivery Vehicles (IDVs) with NIAID, NCI, and NINDS, ABL provides a range of services to support the preclinical and clinical development of medical countermeasures for various infectious diseases and other health conditions. These services include cGMP manufacturing, process development, analytical testing, stability studies, and project management.
Description
This contract is for the contractor to provide support for essential core activities that are to be performed on a regular basis. This includes: 1) project management; 2) quality assurance/quality control; 3) document development; 4) shipping, and 5)
Quick answers
Who was awarded contract HHSN27200039?
HHSN27200039 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 25, 2017.
How much is contract HHSN27200039 worth?
The government has obligated $1,826,332 on HHSN27200039.
Is contract HHSN27200039 an order under another contract?
Yes. HHSN27200039 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200039 competed?
The extent of competition for HHSN27200039 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award